Evan Carter's Hip Surgery Is the Wrong News at the Wrong Time for a Rangers Team Out of Excuses

The Texas Rangers' offseason officially began with a roster move, a waiver claim and a coaching shakeup. It will be remembered, at least in the short term, for a medical report.

Evan Carter underwent surgery to repair a labral issue and hip impingement in his right hip, a procedure that carries roughly a six-month recovery window. President of baseball operations Chris Young acknowledged that while Carter is expected to play for a substantial portion of the 2027 season, he is unlikely to be ready for Opening Day — and Texas will now explore the center field market, per reporting from MLB Trade Rumors.

That is a painful sentence for a team that just finished 80-82, missed the postseason for a third consecutive year, and watched the Astros take the AL West at 81-81. The Rangers were one game and a tiebreaker short of a division title in the worst division race in recent memory. They got there with a minus-46 run differential (673 scored, 719 allowed) and a 4.33 team ERA that undid an offense already short on margin.

The glove was never the problem

Here is the uncomfortable part of the Carter equation: the bat vanished in 2026, the defense did not. In 141 games he hit .194/.288/.315 with nine home runs, 17 steals and 114 strikeouts in 391 at-bats — a .603 OPS that would strain any lineup. Yet his outfield work graded out at 11 outs above average, with a 95 percent actual success rate against a 91 percent estimated rate. He was, by the metrics, an elite center fielder having a lost year at the plate.

So the Rangers aren't really replacing a hitter this spring. They're replacing a premium defensive asset whose offensive baseline has now been reset twice. He posted a .728 OPS in an injury-shortened 2025; 2026 was a step backward on top of a step backward. Betting on a bounceback was always going to require health. Now it requires patience and a contingency plan.

Where the roster actually stands

The rest of the week's activity sketched out the shape of that plan, and it looks lean. Texas declined options on Jakob Junis and Kyle Higashioka, claimed reliever Jose Butto off waivers, outrighted Helman, shook up the coaching staff, and signed a teenage pitching prospect out of Cuba. Young has publicly emphasized youth and athleticism for 2027 — a direction that fits a payroll described in multiple reports as tight ahead of the non-tender deadline, with ownership and a possible lockout adding uncertainty.

The internal candidates exist. Sebastian Walcott is being asked to try the outfield in the Arizona Fall League, a positional experiment that could matter a great deal if Carter's timeline slips. Ezequiel Durán, fresh off a Gold Glove for his versatility, hit .260/.320/.419 with 17 homers and 83 RBI across 153 games and gives the club a movable piece.

But the middle of the order needs more than versatility. Wyatt Langford (.238/.333/.421 in 110 games) has yet to convert talent into production or durability. Jake Burger popped 28 homers but struck out 167 times with a .302 on-base percentage. A team that hit .241 with a .711 OPS and struck out 1,395 times cannot afford to lose a plus defender in center without gaining something real elsewhere.

The ripple effect

The pitching staff is the crux. A 4.33 ERA and 193 home runs allowed demand better outfield defense, not worse, and Carter was the best of it. If Texas fills center field with a bat-first stopgap, the run prevention gets shakier in front of a rotation that already regressed hard from 2025.

Carter's surgery doesn't sink the Rangers' winter. It reorders it. A club with money to spend absorbs this in an afternoon. A club with a tight budget and a self-declared mandate to get younger has to decide whether the answer is Walcott's outfield experiment, a cheap platoon partner, or a trade it can't really afford.